A Budget Impact Model for Paclitaxel-eluting Stent in Femoropopliteal Disease in France

被引：0
|
作者：
Erwin De Cock
Marc Sapoval
Pierre Julia
Greg de Lissovoy
Sandra Lopes
机构：
[1] United BioSource Corporation,Peri
[2] Hôpital Européen Georges Pompidou, and Post
[3] Université René Descartes,Approval Services
[4] Hôpital Européen Georges Pompidou,Department of Cardiovascular and Interventional Radiology
[5] Université René Descartes,Cardiovascular Surgery Department
[6] Johns Hopkins Bloomberg School of Public Health,Department of Health Policy and Management
[7] Cook Medical,Health Economics and Reimbursement
来源：
CardioVascular and Interventional Radiology | 2013年 / 36卷
关键词：
Budget impact model; Drug-eluting stent; Paclitaxel-eluting stent; Peripheral artery disease; Superficial femoral artery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：362 / 370
页数：8
相关论文
共 50 条
  • [1] A Budget Impact Model for Paclitaxel-eluting Stent in Femoropopliteal Disease in France
    De Cock, Erwin
    Sapoval, Marc
    Julia, Pierre
    de Lissovoy, Greg
    Lopes, Sandra
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2013, 36 (02) : 362 - 370
  • [2] THE ADVANTAGE OF PACLITAXEL-ELUTING STENT IMPLANTATION FOR FEMOROPOPLITEAL LESIONS
    Tsutsumi, Masakazu
    Ito, Yoshiaki
    Hirano, Keisuke
    Yamawaki, Masahiro
    Araki, Motoharu
    Kobayashi, Norihiro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1324 - 1324
  • [3] Treatment of Femoropopliteal In-Stent Restenosis With Paclitaxel-Eluting Stents
    Zeller, Thomas
    Dake, Michael D.
    Tepe, Gunnar
    Brechtel, Klaus
    Noory, Elias
    Beschorner, Ulrich
    Kultgen, Patricia L.
    Rastan, Aljoscha
    JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (03) : 274 - 281
  • [4] Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency
    Marples, Rory
    Binks, Matthew
    Spina, Roberto
    Wright, Melissa
    Huilgol, Ravi
    SURGERY OPEN SCIENCE, 2022, 7 : 18 - 21
  • [5] Paclitaxel-coated balloon versus paclitaxel-eluting stent for femoropopliteal arterial disease: A meta-analysis
    Tang, Tingni
    Fang, Jie
    Zhang, Yongbao
    MEDICINE, 2025, 104 (12)
  • [6] Damage to Polymer of Paclitaxel-Eluting Stent
    Kitahara, Hideki
    Kobayashi, Yoshio
    Yamaguchi, Masashi
    Ohkubo, Kenji
    Nakayama, Takashi
    Kuroda, Nakabumi
    Komuro, Issei
    CIRCULATION JOURNAL, 2008, 72 (11) : 1907 - 1908
  • [7] Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease
    Mueller-Huelsbeck, Stefan
    Keirse, Koen
    Zeller, Thomas
    Schroe, Herman
    Diaz-Cartelle, Juan
    JOURNAL OF ENDOVASCULAR THERAPY, 2016, 23 (05) : 701 - 707
  • [8] Analysis of the effect of paclitaxel-eluting stents and paclitaxel-eluting balloon in the treatment of in-stent restenosis
    Cheng, Jiangtao
    Gao, Chuanyu
    Liu, Yuhao
    Wang, Zhongmin
    Zheng, Xiaohui
    Qi, Datun
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 30 (04) : 1521 - 1524
  • [9] Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease
    Kim, Young-Hak
    Park, Seong-Wook
    Lee, Seung-Whan
    Park, Duk-Woo
    Yun, Sung-Cheol
    Lee, Cheol Whan
    Hong, Myeong-Ki
    Kim, Hyun-Sook
    Ko, Jae-Ki
    Park, Jae-Hyeong
    Lee, Jae-Hwan
    Choi, Si Wan
    Seong, In-Whan
    Cho, Yoon Haeng
    Lee, Nae-Hee
    Kim, June Hong
    Chun, Kook-Jin
    Park, Seung-Jung
    CIRCULATION, 2006, 114 (20) : 2148 - 2153
  • [10] A Randomized Comparison of a Zotarolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
    Buellesfeld, L.
    HERZ, 2009, 34 (02) : 166 - 166
12345